|Articles|April 8, 2021

How Labs Can Advance Cell and Gene Therapy Expansion Processes

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Related Content

Particle Risk Mitigation in Biomanucturing

ByEntegris

October 29th 2025

Executive Summary: Charge Detection Mass Spectrometry (CDMS): From Complexity to Clarity – A New Era in Biomolecular Analysis

ByWaters Corporation

October 28th 2025

Executive Summary: Supporting mRNA Development With Quantitative Expression Analysis

BySCIEX

October 23rd 2025

Applying Analytical Quality by Design Principles to Biopharma Method Development and Optimization

ByWaters

October 21st 2025

Executive Summary: Mastering Nitrosamines Analysis With Streamlined LC-MS/MS Solutions

BySCIEX

October 21st 2025

How Labs Can Advance Cell and Gene Therapy Expansion Processes

Newsletter

Related Content

Particle Risk Mitigation in Biomanucturing

Executive Summary: Charge Detection Mass Spectrometry (CDMS): From Complexity to Clarity – A New Era in Biomolecular Analysis

Executive Summary: Supporting mRNA Development With Quantitative Expression Analysis

Applying Analytical Quality by Design Principles to Biopharma Method Development and Optimization

Executive Summary: Mastering Nitrosamines Analysis With Streamlined LC-MS/MS Solutions

Trending on BioPharm International

Can New Funding Models Support Next-Generation Medicines?

In-Vivo Cell Therapy Model Aims to Reduce Manufacturing Challenges

BioPharm Weekly News Roundup—Week of Nov. 3, 2025

Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars